| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 04/19/2005 | US6881850 Heterocyclically annellated indenochromene derivatives |
| 04/19/2005 | US6881753 Potassium channel inhibitors and method |
| 04/19/2005 | US6881749 Pyranoindazoles and their use for the treatment of glaucoma |
| 04/14/2005 | WO2005033930A2 Process for upgrading naphtha |
| 04/14/2005 | WO2005033113A2 Indole derivatives |
| 04/14/2005 | WO2005033112A2 Substituted indole derivatives |
| 04/14/2005 | WO2005033079A1 Novel antifungal agent comprising heterocyclic compound |
| 04/14/2005 | WO2005033073A2 Spirocyclic heterocyclic derivatives and methods of their use |
| 04/14/2005 | WO2005032541A1 Substituted heterocyclic mercaptosulfide inhibitors |
| 04/14/2005 | WO2005007099A3 Pkb inhibitors as anti-tumor agents |
| 04/14/2005 | WO2005002503A3 Asymmetric benzimidazoles and related compounds as potassium channel modulators |
| 04/14/2005 | WO2004105700A3 Compounds, methods and pharmaceutical compositions for inhibiting parp |
| 04/14/2005 | WO2004100891A3 Cytotoxic indeno and isoindoloisoquinolones |
| 04/14/2005 | WO2004013120A8 Novel benzodioxoles |
| 04/14/2005 | US20050080272 Halogenated nitrobutadienes for controlling animal pests |
| 04/14/2005 | US20050080267 Synthesis of enantiomerically pure amino-substituted fused bicyclic rings |
| 04/14/2005 | US20050080266 Nitrogen compounds such as 8,9-dihydroxy-1,2,3,11b-tetrahydro-chromeno(4,3,2-de)isoquinoline hydrobromide, administered for prophylaxis of nervous system disorders |
| 04/14/2005 | US20050080096 Condensed heterocyclic compounds |
| 04/14/2005 | US20050080085 Novel 3beta-amino azabicyclooctane heteroaromatic amid derivatives preparation method and therapeutic uses thereof |
| 04/14/2005 | US20050079455 Colour photographic recording material |
| 04/14/2005 | CA2541014A1 Spirocyclic heterocyclic derivatives and methods of their use |
| 04/14/2005 | CA2540517A1 Process for upgrading naphtha |
| 04/14/2005 | CA2540343A1 Indole derivatives |
| 04/14/2005 | CA2540289A1 Substituted indole derivatives |
| 04/13/2005 | EP1522542A1 Therapeutic or preventive agent for nausea/vomiting |
| 04/13/2005 | EP1521757A1 Novel tricyclic spiropiperidines or spiropyrrolidines |
| 04/13/2005 | EP1366050B1 Condensed pyrazindione derivatives as pde inhibitors |
| 04/13/2005 | EP1268498B1 Cardioprotective phosphonates |
| 04/13/2005 | EP1105728B1 Modulating multiple lineage kinase proteins |
| 04/13/2005 | EP1015469B1 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleoide analogues |
| 04/13/2005 | CN1606545A Pyrrolidine and piperidine derivates as nk1 antagonists |
| 04/13/2005 | CN1606443A Substituted diketopiperazines as oxytocin antagonists |
| 04/13/2005 | CN1196692C Substituted benzopyran derivatives for the treatment of inflammation |
| 04/13/2005 | CN1196485C Compositions for use against parasitic protozoa |
| 04/12/2005 | US6878825 Rylene derivatives and their use as dyes |
| 04/12/2005 | US6878714 Prophylaxis and treatment of angiogenesis mediated diseases such as cancer |
| 04/12/2005 | US6878707 Carboxamides useful as inhibitors of microsomal triglyceride transfer protein and of apolipoprotein b secretion |
| 04/12/2005 | US6878705 Especially agents against viruses of the herpes family. |
| 04/12/2005 | CA2279817C Process for the preparation of substituted piperidine-epoxides |
| 04/12/2005 | CA2122571C Adhesion receptor antagonists |
| 04/07/2005 | WO2005030778A1 Ligands |
| 04/07/2005 | WO2005030774A1 Hcv inhibitors and methods of using them |
| 04/07/2005 | WO2005030713A2 Resolution of a narwedine amide derivative |
| 04/07/2005 | WO2005030711A2 Bridged macrocyclic module compositions |
| 04/07/2005 | WO2005030333A2 Novel derivatives of 4a,5,9,10,11,12-hexahydrobenzofuro[3a,3,2] [2]- benzazepine, method for the production thereof and use thereof in the production of medicaments |
| 04/07/2005 | WO2005030332A2 Use of galanthamine and the derivatives thereof in the production of medicaments |
| 04/07/2005 | WO2005030213A1 1,1,1-trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo |
| 04/07/2005 | WO2005030131A2 Bis-quinazoline compounds for the treatment of bacterial infections |
| 04/07/2005 | WO2004096818A3 Method and compositions for identifying anti-hiv therapeutic compounds |
| 04/07/2005 | WO2004062590A3 Bicyclic carbohydrates as antiprotozoal bioactive for the treatment of infections caused by parasites |
| 04/07/2005 | US20050075383 Inhibitors of phophodiesterase type-IV |
| 04/07/2005 | US20050075364 Viricides, immunomodulators or HIV entry inhibitors; lymphadenopathy associated virus, human T-cell leukemia/lymphoma virus; AIDS |
| 04/07/2005 | US20050075362 Novel anticancer conjugates of camptothecin and unsaturated fatty acids |
| 04/07/2005 | US20050075356 E.g., N-(4-fluorobenzyl)-5,6-dihydroxy-2-[1-methyl-1-(methylamino)ethyl]pyrimidine-4-carboxamide, used for preventing, treating or delaying the onset of and infection by AIDS |
| 04/07/2005 | US20050075348 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor |
| 04/07/2005 | US20050075347 For the prevention and/or therapy of ischaemia and reperfusion damage |
| 04/07/2005 | US20050075332 Tricyclic compounds with antiviral activity |
| 04/07/2005 | US20050074470 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 04/07/2005 | US20050074408 Compounds for fluorescent emission for animals |
| 04/07/2005 | CA2540021A1 Hcv inhibitors and methods of using them |
| 04/07/2005 | CA2539961A1 Novel derivatives of 4a,5,9,10,11,12-hexahydrobenzofuro[3a,3,2] [2]- benzazepine, method for the production thereof and use thereof in the production of medicaments |
| 04/07/2005 | CA2538705A1 Ligands |
| 04/07/2005 | CA2506282A1 Use of galanthamine and the derivatives thereof in the production of medicaments |
| 04/06/2005 | EP1520856A1 Androgen receptor agonist |
| 04/06/2005 | EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators |
| 04/06/2005 | EP1392656A4 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors |
| 04/06/2005 | EP1353909B1 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioidreceptor binding agents |
| 04/06/2005 | EP0748219B1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/06/2005 | CN1604897A 7-amino-benzothiazole derivatives as adenosine receptor ligands |
| 04/06/2005 | CN1603291A Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 04/06/2005 | CN1195758C Optical pure analog of camptothecine |
| 04/06/2005 | CN1195757C Optically pure camptothecin analogues |
| 04/06/2005 | CN1195743C Dihydro-1, 3, 5-triazine amine derivatives and their therapeutic uses |
| 04/06/2005 | CN1195522C Benzodiazepine derivatives |
| 04/06/2005 | CN1195514C Metabolites of ecteinascidin 743 |
| 04/05/2005 | US6875878 Chromene compound |
| 04/05/2005 | US6875867 Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors |
| 04/05/2005 | US6875784 Bactericides; grampositive, gramnegative bacteria |
| 04/05/2005 | US6875761 Certain 1,3-disubstituted isoquinoline derivatives |
| 04/05/2005 | CA2092694C Use of pyridylmethylsulphinyl-1h-benzimidazole derivates in the treatment of illnesses caused by helicobacter bacteria |
| 03/31/2005 | WO2005028475A2 Compositions useful as inhibitors of protein kinases |
| 03/31/2005 | WO2005028440A1 Novel gamma secretase inhibitors |
| 03/31/2005 | WO2004108133A3 Modulators of vr1 receptor |
| 03/31/2005 | WO2004089307A3 Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists |
| 03/31/2005 | US20050070720 11-Beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 03/31/2005 | US20050070713 Neurokinin antagonist; therapy for central nervous system disorders; psychological disorders; Parkinson's and Huntington's disease |
| 03/31/2005 | US20050070609 Cyclopentyl modulators of chemokine receptor activity |
| 03/31/2005 | US20050070590 possessing anti-cancer activity, anti-inflammatory activity, anti-obesity activity, and/or hair growth promotion activity |
| 03/31/2005 | US20050070549 heterocylic amines such as 2-(5-{3-[4-(4-Chloro-2-methyl-phenyl)-piperazin-1-yl]-propylidene}-5,11-dihydro-10-oxa-1-aza-dibenzo[a,d]cyclohepten-7-yl)-propan-2-ol, used for treating diseases associated with aberrant leukocyte recruitment and/or activation |
| 03/31/2005 | US20050070547 Useful in treatment of conditions associated with pathological receptor activation in humans, domesticated companion animals and livestock animals; for treating conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, overactive bladder, cough, hiccup |
| 03/31/2005 | US20050070541 Enzyme inhibitors of cGMP-metabolizing phosphodiesterases, for TREATMENT OF CARDIOVASCULAR DIORDERS, CEREBROVASCULAR DISORDERS, UROGENITAL DISORDERS AND ERECTILE DYSFUNCTION; chemical synthesis |
| 03/31/2005 | US20050070522 Dissolving racemic bromoamide in organic solvent containing a soluble base, seeding, then crystallizing |
| 03/31/2005 | CA2538590A1 Novel gamma secretase inhibitors |
| 03/31/2005 | CA2537731A1 Compositions useful as inhibitors of protein kinases |
| 03/30/2005 | EP1518553A2 Use of nitrate ester compounds for treating pain or providing analgesia |
| 03/30/2005 | EP1517908A2 Novel benzimidazole derivatives |
| 03/30/2005 | EP1517689A2 Selective analgesic agents |
| 03/30/2005 | CN1602196A Ureas of 2-aminobenzothiazoles as adenosine modulators |
| 03/30/2005 | CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 03/30/2005 | CN1600772A Aryl phenyl substituted cyclic ketoenols |